Sf9

Sf9 Full Name

Insect Cell Line SF9

Sf9 Introduction

The Sf9 cell line is one of the most widely used insect cell lines in modern biotechnology and biopharmaceuticals, renowned for its robust growth characteristics and high efficiency in protein expression. In terms of lineage, Sf9 is not an independent primary cell line but rather a clonal isolate derived from its parental line, IPLB-SF21-AE. This cloning process selected for cell populations with faster growth rates and greater adaptability to in vitro culture conditions, laying the foundation for its extensive application in both industry and academia. Regarding culture characteristics, Sf9 cells exhibit remarkable adaptability. Their optimal growth temperature is typically maintained between 27°C and 28°C, significantly lower than the 37°C required for mammalian cells, which reduces energy consumption during cultivation. Sf9 cells can grow both adherently and in high-density suspension cultures in bioreactors—the latter being a key feature for large-scale industrial production. The cells can thrive in various culture media formulations, and their ability to grow in serum-free media is a significant advantage. This not only greatly simplifies downstream purification processes for recombinant proteins by avoiding interference from complex serum proteins but also notably reduces production costs. Moreover, it eliminates biosafety risks associated with potential contaminants such as viruses or prions from animal-derived serum, making Sf9 an ideal host cell for producing human vaccines and therapeutic proteins.

The core value of Sf9 cells lies in their role as a key host for the Baculovirus Expression Vector System (BEVS), forming a powerful, efficient, and versatile platform for recombinant protein production. Compared with traditional prokaryotic expression systems such as E. coli, the Sf9-BEVS system offers unparalleled advantages. As eukaryotic cells, Sf9 possesses relatively complete protein processing and modification machinery. It can perform complex post-translational modifications (PTMs) on newly synthesized polypeptide chains, including proper disulfide bond formation, signal peptide cleavage, glycosylation, phosphorylation, and oligomerization. These modifications are essential for maintaining the correct spatial conformation and full biological activity of many complex mammalian or viral proteins—a capability lacking in bacterial expression systems. Additionally, the system boasts several prominent strengths. First, it offers high safety: baculoviruses used in this system, such as Autographa californica multiple nucleopolyhedrovirus (AcMNPV), are highly host-specific, infecting only certain insect species and posing no pathogenicity to humans or other vertebrates. This allows for lower biosafety requirements throughout the process. Second, it achieves high expression yields, meeting production demands from laboratory research to industrial-scale manufacturing. Finally, the system is easily scalable. The suspension culture properties of Sf9 cells enable seamless scaling from flask cultures to bioreactors with volumes ranging from hundreds to thousands of liters, providing a solid technical foundation for the commercial development of biopharmaceuticals.

Figure 1. Comparison between Sf21 and Sf9 insect cell lines. (Source: Kwiatkowska J, et al. 2025)

Alternate Names for Sf9

Insect Cell Line SF9; SF9

• 1. Kwiatkowska J, et al. A beginners guide to Sf9 and Sf21 insect cell line culture and troubleshooting. Sci Rep. 2025 Jun 6;15(1):19907.
  2. Schneider EH, et al. Sf9 cells: a versatile model system to investigate the pharmacological properties of G protein-coupled receptors. Pharmacol Ther. 2010 Dec;128(3):387-418.